The Worlds #1 Renewable Energy Network for News & Information
Sign In
or
Register
Sections
Home
Solar
Wind
Geothermal
Bio
Hydro
Careers
Companies
Webcasts
White Papers
Magazines
Awards
Account
Sign In
Register
Search
REW 40 Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Celgene Corp
(NQ:
CELG
)
122.58
USD
-1.06 (-0.86%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 24, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
122.61
Bid (Size)
122.58 (300)
Ask (Size)
122.59 (500)
Prev. Close
123.64
Today's Range
121.66 - 123.71
52wk Range
58.53 - 131.41
Shares Outstanding
417,122,477
Dividend Yield
N/A
Top News
More News
Investing in Cancer Research Is Worth the Risk: Echo He
May 23, 2013
Source: George S. Mack of The Life Sciences Report (5/23/13) http://www.thelifesciencesreport.com/pub/na/15301 If investigators could find a way to make breast cancer survivors truly cancer free, and...
Read More
category
RHHBY
,
INFI
,
CELG
, and 5 more.
from
Bio-Wire.Com
Celgene anuncia que la FDA de Estados Unidos ha concedido la revisión prioritaria para la solicitud complementaria de nuevo fármaco para ABRAXANE® en el cáncer pancreático avanzado
May 23, 2013
from
Business Wire Spanish
More News
Read More
Celgene Announces U.S. FDA Grants Priority Review for ABRAXANE® sNDA in Advanced Pancreatic Cancer
May 23, 2013
from
Business Wire News Releases
Celgene (CELG) Granted FDA Priority Review for ABRAXANE sNDA in Advanced Pancreatic Cancer
May 23, 2013
from
StreetInsider.com News Articles
iShares Nasdaq Biotechnology Index Fund Experiences Big Outflow
May 22, 2013
category
ETFs
from
ETF Channel
Celgene Corporation (CELG) - Daily Trading Review
May 22, 2013
from
AVAFIN
Today’s Research on CELG, ARNA, INCY, SPPI, and GERN
May 21, 2013
from
ACCESSWIRE
Options Players Wage on Celgene Corporation
May 16, 2013
from
AVAFIN
Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest EPS Estimates For The Next Quarter
May 15, 2013
category
Benzinga
,
Highest EPS Estimates
,
CELG
, and 6 more.
from
Latest Articles from Benzinga.com
Jim Cramer's 5 Investing Sweet Spots
May 14, 2013
category
Regeneron Pharmaceuticals Inc
,
EOG Resources Inc
,
ENSCO International Incorporated
, and 14 more.
from
CNBC.com News
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here